Testing effectiveness (Phase 2)Study completedNCT02494921What this trial is testingLEE011 (Ribociclib) in Combination With Docetaxel Plus Prednisone in mCRPCWho this might be right forProstate Cancer Rahul Aggarwal 43
Testing effectiveness (Phase 2)Active Not RecruitingNCT06334432What this trial is testingSafety and Efficacy Study of NUV-1511 in Adult Patients With Advanced Solid TumorsWho this might be right forAdvanced Solid TumorHER2-negative Breast CancerMetastatic Castration-resistant Prostate Cancer (mCRPC)+2 more Nuvation Bio Inc. 466
Testing effectiveness (Phase 2)Ended earlyNCT01717898What this trial is testingPhase I/II Trial of Abiraterone Acetate + BEZ235 in Metastatic, Castration-Resistant Prostate CancerWho this might be right forCastrate-resistant Prostate Cancer Charles Ryan 6
Early research (Phase 1)Not Yet RecruitingNCT07090369What this trial is testingPhase Ib Trial of 177Lu-PSMA-I&T Therapy in Combination With Olaparib and Pembrolizumab in Patients With Metastatic Castration Resistant Prostate CancerWho this might be right forMetastatic Castrate Resistant Prostate Cancer (mCRPC) Peter MacCallum Cancer Centre, Australia 20
Not applicableEnded earlyNCT02042053What this trial is testingPET/MR Assessment of Sipuleucel T Treatment for Metastatic Castration Resistant Prostate CancerWho this might be right forProstate Cancer NYU Langone Health 10
Early research (Phase 1)Ended earlyNCT04615845What this trial is testingAutologous Dendritic Cell Immunotherapy in Patients With mCRPCWho this might be right forMetastatic Castration Resistant Prostate Cancer Pharmicell Co., Ltd. 3
Large-scale testing (Phase 3)Study completedNCT01810770What this trial is testingRadium-223 Dichloride Asian Population Study in the Treatment of CRPC Patients With Bone MetastasisWho this might be right forProstatic Neoplasms Bayer 243
Testing effectiveness (Phase 2)UnknownNCT02935205What this trial is testingEnzalutamide and Indomethacin in Treating Patients With Recurrent or Metastatic Hormone-Resistant Prostate CancerWho this might be right forMetastatic Prostate CarcinomaRecurrent Prostate CarcinomaStage IV Prostate Cancer Mamta Parikh 38
Testing effectiveness (Phase 2)Study completedNCT03568656What this trial is testingStudy to Evaluate CCS1477 in Advanced TumoursWho this might be right forMetastatic Castration-Resistant Prostate CancerMetastatic Breast CancerNon-small Cell Lung Cancer+1 more CellCentric Ltd. 220
Testing effectiveness (Phase 2)Looking for participantsNCT07181161What this trial is testingStudy of AZD0516 as Monotherapy and in Combination in Participants With Metastatic Prostate CancerWho this might be right forMetastatic Prostate Cancer AstraZeneca 283
Large-scale testing (Phase 3)Study completedNCT00036556What this trial is testingStudy of Atrasentan in Men With Non-Metastatic, Hormone-Refractory Prostate CancerWho this might be right forProstatic Neoplasms Abbott 941
Not applicableStudy completedNCT01062503What this trial is testingDuration of Suppression of Bone Turnover Following Treatment With Zoledronic Acid in Men With Metastatic CRPCWho this might be right forMetastatic Prostate CancerBone Metastasis University Health Network, Toronto 48
Testing effectiveness (Phase 2)WithdrawnNCT01087580What this trial is testingDocetaxel + Prednisone With or Without Radiation for Castrate Resistant Prostate CancerWho this might be right forPROSTATE CANCER Northwestern University
Testing effectiveness (Phase 2)WithdrawnNCT02906605What this trial is testingThe Clinical Activity and Safety of JNJ-64041809, a Live Attenuated Listeria Monocytogenes Immunotherapy, in Combination With Apalutamide Versus Apalutamide in Subjects With Metastatic Castration-resistant Prostate CancerWho this might be right forProstatic Neoplasms, Castration-Resistant Janssen Research & Development, LLC
Testing effectiveness (Phase 2)Study completedNCT01487720What this trial is testingGEMOX in Docetaxel-Refractory Castration-Resistant Prostate CancerWho this might be right forProstate Cancer Asan Medical Center 33
Early research (Phase 1)Study completedNCT04428788What this trial is testingStudy to Evaluate the Safety and Tolerability of CC-94676 in Participants With Metastatic Castration-Resistant Prostate CancerWho this might be right forProstatic Neoplasms Celgene 131
Testing effectiveness (Phase 2)Study completedNCT01075308What this trial is testingSB939 in Treating Patients With Recurrent or Metastatic Prostate CancerWho this might be right forProstate Cancer NCIC Clinical Trials Group 32
Early research (Phase 1)Study completedNCT02262910What this trial is testingStudy of ES414 in Metastatic Castration-Resistant Prostate CancerWho this might be right forProstate Cancer Aptevo Therapeutics 35
Early research (Phase 1)Ended earlyNCT05252390What this trial is testingNUV-868 as Monotherapy and in Combination With Olaparib or Enzalutamide in Adult Patients With Advanced Solid TumorsWho this might be right forAdvanced Solid TumorOvarian CancerOvary Cancer+24 more Nuvation Bio Inc. 82
Testing effectiveness (Phase 2)Active Not RecruitingNCT05502315What this trial is testingStudy of Cabozantinib and Nivolumab in Metastatic Castration Resistant Prostate CancerWho this might be right forCastration-resistant Prostate CancerMetastatic Cancer Rana McKay, MD 47